Cargando…

Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway

BACKGROUND: Sevoflurane can protect organs from ischemia-reperfusion (IR) injury, but the mechanism is still unclear. MicroRNA-122 (miR-122) is a liver-specific microRNA (miRNA) and regulates liver function. Therefore, this study aims to elucidate the relationship between the protective effect of se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kai, Xu, Xia, Hu, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011315/
https://www.ncbi.nlm.nih.gov/pubmed/35433991
http://dx.doi.org/10.21037/atm-22-115
_version_ 1784687663515697152
author Zhang, Kai
Xu, Xia
Hu, Lihong
author_facet Zhang, Kai
Xu, Xia
Hu, Lihong
author_sort Zhang, Kai
collection PubMed
description BACKGROUND: Sevoflurane can protect organs from ischemia-reperfusion (IR) injury, but the mechanism is still unclear. MicroRNA-122 (miR-122) is a liver-specific microRNA (miRNA) and regulates liver function. Therefore, this study aims to elucidate the relationship between the protective effect of sevoflurane and miR-122 in liver IR injury. METHODS: Wistar rats were divided into the following groups: sham, IR, IR + sevoflurane, IR + miR-122 antagomir, and IR + miR-122 antagomir + sevoflurane. Hematoxylin and eosin (H&E) staining and Suzuki score were used to evaluate the pathological damage of the liver. The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-10 in the serum and the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO) in the liver homogenate supernatant were detected by using the corresponding kit. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) and flow cytometry was applied to evaluate the apoptosis of liver tissues. The expression of nuclear factor E2-related factor 2 (Nrf2), miR-122, p53, and HO-1 in liver tissue was evaluated by using immunohistochemistry, qRT-PCR, and western blot as needed. RESULTS: Compared to the IR group, the sevoflurane post-treatment or miR-122 antagomir groups showed improved liver injury, decreased Suzuki score, inhibited the levels of AST, ALT, LDH, MDA, NO, TNF-α, IL-1β, and IL-6, increased levels of SOD, IL-10, and inhibited hepatocyte apoptosis. Regarding the molecular mechanism, sevoflurane post-treatment fostered the expression of HO-1, promoted the transport of Nrf2 from cytoplasm to the nucleus, and decreased the expression of miR-122 and p53. The combined use of miR-122 antagomir and sevoflurane enhanced the protective effect of miR-122 antagomir in liver injury in IR rats. CONCLUSIONS: Sevoflurane protected the liver from IR damage by regulating the miR-122/Nrf2/HO-1 pathway.
format Online
Article
Text
id pubmed-9011315
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-90113152022-04-16 Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway Zhang, Kai Xu, Xia Hu, Lihong Ann Transl Med Original Article BACKGROUND: Sevoflurane can protect organs from ischemia-reperfusion (IR) injury, but the mechanism is still unclear. MicroRNA-122 (miR-122) is a liver-specific microRNA (miRNA) and regulates liver function. Therefore, this study aims to elucidate the relationship between the protective effect of sevoflurane and miR-122 in liver IR injury. METHODS: Wistar rats were divided into the following groups: sham, IR, IR + sevoflurane, IR + miR-122 antagomir, and IR + miR-122 antagomir + sevoflurane. Hematoxylin and eosin (H&E) staining and Suzuki score were used to evaluate the pathological damage of the liver. The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-10 in the serum and the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO) in the liver homogenate supernatant were detected by using the corresponding kit. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) and flow cytometry was applied to evaluate the apoptosis of liver tissues. The expression of nuclear factor E2-related factor 2 (Nrf2), miR-122, p53, and HO-1 in liver tissue was evaluated by using immunohistochemistry, qRT-PCR, and western blot as needed. RESULTS: Compared to the IR group, the sevoflurane post-treatment or miR-122 antagomir groups showed improved liver injury, decreased Suzuki score, inhibited the levels of AST, ALT, LDH, MDA, NO, TNF-α, IL-1β, and IL-6, increased levels of SOD, IL-10, and inhibited hepatocyte apoptosis. Regarding the molecular mechanism, sevoflurane post-treatment fostered the expression of HO-1, promoted the transport of Nrf2 from cytoplasm to the nucleus, and decreased the expression of miR-122 and p53. The combined use of miR-122 antagomir and sevoflurane enhanced the protective effect of miR-122 antagomir in liver injury in IR rats. CONCLUSIONS: Sevoflurane protected the liver from IR damage by regulating the miR-122/Nrf2/HO-1 pathway. AME Publishing Company 2022-03 /pmc/articles/PMC9011315/ /pubmed/35433991 http://dx.doi.org/10.21037/atm-22-115 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhang, Kai
Xu, Xia
Hu, Lihong
Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway
title Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway
title_full Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway
title_fullStr Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway
title_full_unstemmed Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway
title_short Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway
title_sort sevoflurane attenuates hepatic ischemia reperfusion injury by the mir-122/nrf2 pathway
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011315/
https://www.ncbi.nlm.nih.gov/pubmed/35433991
http://dx.doi.org/10.21037/atm-22-115
work_keys_str_mv AT zhangkai sevofluraneattenuateshepaticischemiareperfusioninjurybythemir122nrf2pathway
AT xuxia sevofluraneattenuateshepaticischemiareperfusioninjurybythemir122nrf2pathway
AT hulihong sevofluraneattenuateshepaticischemiareperfusioninjurybythemir122nrf2pathway